K Health, a New York-based AI-driven primary care company on a mission to provide access to high-quality medical care at scale, has secured $50 million in funding.
Investors
The round was led by Claure Group, with additional support from Pablo Legorreta (founder and CEO of Royalty Pharma), and existing investors Mangrove Capital Partners, Valor Equity Partners, and Atreides Management, LP.
Founded in 2018, Claure Group is a global entrepreneurial and investment firm spanning multiple high-growth sectors including telecom, tech, media, real estate, infrastructure, climate & energy transition, fashion, and sports.
K Health Use of Funds
The company will use the fresh investment to expand clinical artificial intelligence in personalized primary care within leading health systems.
About K Health
K Health specializes in AI-powered healthcare solutions, specifically focusing on primary care. The company has developed a platform that utilizes advanced artificial intelligence to enhance the efficiency and personalization of healthcare delivery. Its 24/7 virtual primary care solution is accessible to millions of people in the U.S. through leading health systems and insurers, as well as via a direct-to-consumer mobile app. K Health’s platform includes medical chat and AI predictive models based on large datasets, enabling physicians to optimize diagnosis and treatment while prioritizing patient care.
Funding Details
Company: K Health, Inc.
Raised: $50.0M
Round: Unknown
Funding Month: July 2024
Lead Investors: Claure Group
Additional Investors: Pablo Legorreta, Mangrove Capital Partners, Valor Equity Partners, Atreides Management, LP
Company Website: https://www.khealth.com/
Software Category: Healthcare Solutions
Source: https://www.businesswire.com/news/home/20240701313131/en/